Literature DB >> 3237690

Pathology of the lymph node and spleen in systemic mast cell disease.

W D Travis1, C Y Li.   

Abstract

The spleen and lymph node are two of the most common organs involved in systemic mast cell disease (SMCD). However, SMCD infiltrates in the spleen and lymph node have a broad spectrum of morphological patterns which can make it difficult to recognize the diagnosis, especially when specimens are examined from patients in whom SMCD is not suspected. We reviewed the pathological features of 16 spleen and 23 lymph node specimens from 19 patients which represented all available material from a series of 58 Mayo Clinic patients with SMCD. The purpose of this study was to investigate the pathological manifestations of SMCD involvement in the spleen and lymph node and to address difficulties in differential diagnosis. All compartments of the spleen and lymph node were found to be affected by SMCD. SMCD lesions in the spleen were found in a paratrabecular (92%), parafollicular (69%), follicular (15%), and a diffuse red pulp (8%) distribution. In the lymph node, mast cell infiltrates affected the paracortex (88%), the parafollicular region (50%), the follicles (25%), the medullary cords (13%), and the sinuses (6%). Mast cells were frequently found in a perivascular location, and associated eosinophilia was common. Because of the broad spectrum of histological manifestations of SMCD in the spleen and lymph node, a wide range of differential diagnoses is discussed including follicular lymphoma, T-cell lymphoma, monocytoid B-cell hyperplasia and lymphoma, Kaposi's sarcoma, and Langerhans' cell granulomatosis.

Entities:  

Mesh:

Year:  1988        PMID: 3237690

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

Review 1.  Gastrointestinal manifestations of systemic mastocytosis.

Authors:  Jason K Lee; Scott J Whittaker; Robert A Enns; Peter Zetler
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

2.  Different patterns of spleen involvement in systemic and malignant mastocytosis. A histological and immunohistochemical study of three cases.

Authors:  J Diebold; O Riviere; B Gosselin; A Janin-Mercier; A Canelhas; A Le Tourneau; J Audouin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

4.  Regulation of normal and neoplastic human mast cell development in mastocytosis.

Authors:  Dean D Metcalfe
Journal:  Trans Am Clin Climatol Assoc       Date:  2005

Review 5.  KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.

Authors:  M Arock; K Sotlar; C Akin; S Broesby-Olsen; G Hoermann; L Escribano; T K Kristensen; H C Kluin-Nelemans; O Hermine; P Dubreuil; W R Sperr; K Hartmann; J Gotlib; N C P Cross; T Haferlach; A Garcia-Montero; A Orfao; J Schwaab; M Triggiani; H-P Horny; D D Metcalfe; A Reiter; P Valent
Journal:  Leukemia       Date:  2015-02-04       Impact factor: 11.528

6.  Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management.

Authors:  Francesca Crupi; Benedetta Sordi; Fiorenza Vanderwert; Francesca Gesullo; Andrea Amorosi; Francesco Mannelli; Raffaella Santi
Journal:  Int J Mol Sci       Date:  2022-08-07       Impact factor: 6.208

7.  A case of systemic mastocytosis mimicking POEMS syndrome: A case report.

Authors:  Yanqiu Hou; Suyu Jiang; Lu Zhang; Yan Wang; Liubo Zhang; Hongyu Bao; Qingqi Meng; Xue Han; Wanru Chen; Tiantian Li; Jie Peng; Yilin Zhu; Rong Huang; Jingan Liu; Jianning Wang; Chao Fang; Xiaofeng Shi
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.